REPORTS

Let’s Pullulate and Expand Your Business

Peptide Market - Global Professional Analysis and Forecast to 2026

Oct 13, 2019  |  175 PAGES  |  REPORT CODE: CMM207445
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Peptide market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.3% during the forecast period.

This report presents the market size and development trends by detailing the Peptide market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Peptide market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Peptide industry and will help you to build a panoramic view of the industrial development.

Peptide Market, By Type:

  • GMP Peptide

  • Early Phase

Peptide Market, By Application:

  • Commercial

  • Academic Research

Some of the leading players are as follows:

  • ScinoPharm

  • CPC Scientific

  • Thermofisher

  • GL Biochem

  • Hybio

  • Bachem

  • Caslo

  • LifeTein

  • Proimmune

  • AnaSpec

  • Genscript

  • Eurogentec

  • Cambridge peptides

  • Pepscan

  • New England Peptide

  • JPT

  • Biomatik

  • Mimotopes

  • Polypeptide

  • 21st Century Bio

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Peptide Market: Technology Type Analysis

  • 4.1 Peptide Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Peptide Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 GMP Peptide

    • 4.3.2 Early Phase

5 Peptide Market: Product Analysis

  • 5.1 Peptide Product Market Share Analysis, 2018 & 2026

  • 5.2 Peptide Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Peptide Market: Application Analysis

  • 6.1 Peptide Application Market Share Analysis, 2018 & 2026

  • 6.2 Peptide Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Commercial

    • 6.3.2 Academic Research

7 Peptide Market: Regional Analysis

  • 7.1 Peptide Regional Market Share Analysis, 2018 & 2026

  • 7.2 Peptide Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 ScinoPharm

    • 9.1.1 ScinoPharm Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 CPC Scientific

    • 9.2.1 CPC Scientific Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Thermofisher

    • 9.3.1 Thermofisher Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 GL Biochem

    • 9.4.1 GL Biochem Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Hybio

    • 9.5.1 Hybio Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Bachem

    • 9.6.1 Bachem Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Caslo

    • 9.7.1 Caslo Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 LifeTein

    • 9.8.1 LifeTein Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Proimmune

    • 9.9.1 Proimmune Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 AnaSpec

    • 9.10.1 AnaSpec Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Genscript

    • 9.11.1 Genscript Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Eurogentec

    • 9.12.1 Eurogentec Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Cambridge peptides

    • 9.13.1 Cambridge peptides Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Pepscan

    • 9.14.1 Pepscan Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 New England Peptide

    • 9.15.1 New England Peptide Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 JPT

    • 9.16.1 JPT Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Biomatik

    • 9.17.1 Biomatik Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Mimotopes

    • 9.18.1 Mimotopes Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Polypeptide

    • 9.19.1 Polypeptide Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 21st Century Bio

    • 9.20.1 21st Century Bio Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

 

The List of Tables and Figures (Totals 113 Figures and 154 Tables)

  • Figure GMP Peptide Peptide market, 2015 - 2026 (USD Million)

  • Figure Early Phase Peptide market, 2015 - 2026 (USD Million)

  • Figure Commercial market, 2015 - 2026 (USD Million)

  • Figure Academic Research market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Peptide market, by country, 2015 - 2026 (USD Million)

  • Table North America Peptide market, by type, 2015 - 2026 (USD Million)

  • Table North America Peptide market, by product, 2015 - 2026 (USD Million)

  • Table North America Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Peptide market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Peptide market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Canada Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Canada Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Europe Peptide market, by country, 2015 - 2026 (USD Million)

  • Table Europe Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Europe Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Europe Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Peptide market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Peptide market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Germany Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Germany Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Peptide market, by type, 2015 - 2026 (USD Million)

  • Table France Peptide market, by product, 2015 - 2026 (USD Million)

  • Table France Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Italy Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Italy Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Spain Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Spain Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Peptide market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Peptide market, by type, 2015 - 2026 (USD Million)

  • Table China Peptide market, by product, 2015 - 2026 (USD Million)

  • Table China Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Japan Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Japan Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Peptide market, by type, 2015 - 2026 (USD Million)

  • Table India Peptide market, by product, 2015 - 2026 (USD Million)

  • Table India Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Peptide market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Peptide market, by application, 2015 - 2026 (USD Million)

  • Table MEA Peptide market, by country, 2015 - 2026 (USD Million)

  • Table MEA Peptide market, by type, 2015 - 2026 (USD Million)

  • Table MEA Peptide market, by product, 2015 - 2026 (USD Million)

  • Table MEA Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Peptide market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Peptide market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Peptide market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Peptide market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Peptide market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table ScinoPharm Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CPC Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermofisher Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GL Biochem Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hybio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bachem Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Caslo Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LifeTein Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Proimmune Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AnaSpec Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genscript Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eurogentec Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cambridge peptides Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pepscan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table New England Peptide Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table JPT Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biomatik Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mimotopes Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Polypeptide Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table 21st Century Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top